VXL.V - Vaxil Bio Ltd.

TSXV - TSXV Real Time Price. Currency in CAD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-691
-584
-986
-1,358
-1,154
Depreciation & amortization
19
2
25
57
100
Stock based compensation
12
17
70
150
142
Change in working capital
-24
-169
-193
37
307
Accounts receivable
11
11
82
-97
48
Accounts Payable
-
-
-275
-30
283
Other working capital
-684
-734
-1,084
-1,103
-596
Other non-cash items
-
-
-
11
9
Net cash provided by operating activites
-684
-734
-1,084
-1,103
-596
Cash flows from financing activities
Debt repayment
0
0
-9
-57
-68
Common stock issued
-
-
0
755
0
Net cash used privided by (used for) financing activities
35
0
1,808
2,557
-68
Net change in cash
-649
-734
724
1,454
-664
Cash at beginning of period
2,326
2,241
1,510
83
753
Cash at end of period
1,677
1,510
2,241
1,510
83
Free Cash Flow
Operating Cash Flow
-684
-734
-1,084
-1,103
-596
Free Cash Flow
-684
-734
-1,084
-1,103
-596